Finance

Lists
Why is INTS down 14,01%?
Dive Deeper
INTS:NASDAQ
Intensity Therapeutics Inc
2,64 USD
-14,01%
(-0,43) 1D
17-ноя., 15:07:56 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INTS...
Open
2,92 USD
High
2,96 USD
Low
2,59 USD
Mkt. cap
8,72 млн
Avg. vol.
19,13 миң
Volume
20,32 миң
52-wk high
15,00 USD
52-wk low
2,59 USD
EPS
-4,47 USD
Beta
3,01
Shares outstanding
3,30 млн
No. of employees
5
Open
2,92 USD
High
2,96 USD
Low
2,59 USD
Mkt. cap
8,72 млн
Avg. vol.
19,13 миң
Volume
20,32 миң
52-wk high
15,00 USD
52-wk low
2,59 USD
EPS
-4,47 USD
Beta
3,01
Shares outstanding
3,30 млн
No. of employees
5
News stories
From web sources and news partners
About Intensity Therapeutics Inc
CEO-
Employees5
Founded2012
HeadquartersШелтон, Коннектикут, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Analyst ratings
Based on 1 analyst giving stock ratings to INTS in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INTS in the last 3 months
Highest
Current 2,64 USD
7,00 USD (+165,15%)
Average
7,00 USD (+165,15%)
Lowest
7,00 USD (+165,15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
7,00 USD
+165,2%
11/06/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
15,00 USD
+468,2%
08/11/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Upgraded
20,00 USD
+657,6%
03/30/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
30,00 USD
+1 036,4%
03/30/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,50 млн
1,20 млн
1,83 млн
2,43 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,64 млн
1,33 млн
1,25 млн
1,19 млн
Operating expense
3,14 млн
2,53 млн
3,08 млн
3,62 млн
Total operating expenses
3,14 млн
2,53 млн
3,08 млн
3,62 млн
Operating income
-3,14 млн
-2,53 млн
-3,08 млн
-3,62 млн
Other non operating income
1,00 миң
-2,00 миң
-
-3,00 миң
EBT including unusual items
-3,05 млн
-2,43 млн
-3,01 млн
-3,54 млн
EBT excluding unusual items
-3,05 млн
-2,43 млн
-3,01 млн
-3,54 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,05 млн
-2,43 млн
-3,01 млн
-3,54 млн
Net profit margin
-
-
-
-
Earnings per share
-
-0,96
-1,11
-1,09
Interest and investment income
88,00 миң
94,00 миң
77,00 миң
82,00 миң
Interest expense
-
-
-
-
Net interest expenses
88,00 миң
94,00 миң
77,00 миң
82,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору